Literature DB >> 479150

Dissociation of thrombin from platelets by hirudin. Evidence for receptor processing.

S W Tam, J W Fenton, T C Detwiler.   

Abstract

Hirudin inhibited the binding of human 125I-alpha-thrombin to the saturable, but not the nonsaturable, sites on washed human platelets. When hirudin was added to a thrombin-platelet mixture, it caused a biphasic dissociation of bound thrombin. A partial dissociation was too rapid to measure and was followed by complete dissociation with a first order rate constant of about 10(-2) s-1. The fraction of bound thrombin in the more slowly dissociable form increased from essentially none after a 5-s preincubation of thrombin and platelets to as much as 75% of saturable binding after a 4-min preincubation. Transition to the slowly dissociable state was not accompanied by an increase in the amount bound and was not observed with active site serine-derivatized thrombin. This is the first evidence with intact platelets of a binding characteristic that depends, as does platelet stimulation, on catalytically active thrombin, suggesting that it may represent physiologically significant receptor processing.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 479150

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Evidence for tight metabolic control of the receptor-activated polyphosphoinositide cycle in human platelets.

Authors:  V M Steen; O B Tysnes; H Holmsen
Journal:  Biochem J       Date:  1989-10-15       Impact factor: 3.857

2.  Anion channel blockers cause apparent inhibition of exocytosis by reacting with agonist or secretory product, not with cell.

Authors:  J G Vostal; D M Reid; C E Jones; N R Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

3.  Thrombin-induced phosphoinositide hydrolysis in platelets. Receptor occupancy and desensitization.

Authors:  E M Huang; T C Detwiler
Journal:  Biochem J       Date:  1987-02-15       Impact factor: 3.857

4.  Identification of the thrombin receptor on human platelets by chemical crosslinking.

Authors:  J Takamatsu; M K Horne; H R Gralnick
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

5.  Tight coupling of thrombin-induced acid hydrolase secretion and phosphatidate synthesis to receptor occupancy in human platelets.

Authors:  H Holmsen; C A Dangelmaier; S Rongved
Journal:  Biochem J       Date:  1984-08-15       Impact factor: 3.857

6.  Hirudin as a molecular probe for thrombin in vitro and during systemic coagulation in the pig.

Authors:  P Zoldhelyi; J H Chesebro; W G Owen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

7.  Mechanisms of thrombin-induced modifications of human platelet cytoskeleton.

Authors:  F Sinigaglia; C L Balduini; A Bisio; C Balduini
Journal:  Biochem J       Date:  1985-11-15       Impact factor: 3.857

8.  Antithrombotic effect of a novel recombinant hirudin analogue, CX-397, in a rat arterial thrombosis model.

Authors:  Y Takiguchi; F Asai; K Wada; H Hayashi; M Nakashima
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

9.  The energetics of early platelet responses. Energy consumption during shape change and aggregation with special reference to protein phosphorylation and the polyphosphoinositide cycle.

Authors:  A J Verhoeven; G Gorter; M E Mommersteeg; J W Akkerman
Journal:  Biochem J       Date:  1985-06-01       Impact factor: 3.857

10.  Thrombin-receptor agonist peptides, in contrast to thrombin itself, are not full agonists for activation and signal transduction in human platelets in the absence of platelet-derived secondary mediators.

Authors:  L F Lau; K Pumiglia; Y P Côté; M B Feinstein
Journal:  Biochem J       Date:  1994-10-15       Impact factor: 3.857

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.